Bloomage Biotechnology Corporation Limited (688363.SH) announced that Guoshou Chengda intends to reduce its shareholding in the company by up to 9.6336 million shares, representing no more than 2% of the total share capital. The planned divestment will be executed through block trades or centralized bidding, subject to market conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments